Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

venetoclax 23 ibrutinib 13 Rituximab 13 Cyclophosphamide 13 obinutuzumab 10 fludarabine 9 pirtobrutinib 8 Specimen Handling 7 zanubrutinib 6 Biopsy 6 Bendamustine Hydrochloride 6 acalabrutinib 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Prednisone 4 Lenalidomide 4 Vincristine 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 idelalisib 2 Tacrolimus 2 Surveys and Questionnaires 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Chlorambucil 2 ARQ531 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡